A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma

NCT02748135 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Medulloblastoma (MB), Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)

Interventions

DRUG: TB-403 20mg/kg
DRUG: TB-403 50mg/kg
DRUG: TB-403 100mg/kg
DRUG: TB-403 175mg/kg

Sponsor

Oncurious NV

Collaborators

[object Object]